JPMorgan raises Eli Lilly's price target to 1500 USD
BIBIBI
AT A GLANCE
JPMorgan said it would raise Eli Lilly's price target from 1400 USD to 1500 USD。
Article
JPMorgan: Raising Eli Lilly's price target from 1400 USD to 1500 USD BlockBeats news,September 28, JPMorgan said it would raise Eli Lilly (LLY.N)'s price target from 1400 USD to 1500 USD.
Original link https://m.theblockbeats.info/flash/369263
Key points
01
BlockBeats said the news was published on September 28。
02
JPMorgan said it would raise Eli Lilly's (LLY.N) price target from 1400 USD to 1500 USD。
AI-assisted interpretation
The following is analysis, separate from reported facts. Verify important claims independently.
This news indicates that JPMorgan raised the price target it set for Eli Lilly. The original text did not explain the reason for the increase or provide any other rating information.
Why it matters to readers
price target from 1400 USD raise to 1500 USD, signaling a clear change in JPMorgan's assessment of Eli Lilly's price target.
Beginners should distinguish between a price target and the actual trading price; this material only states that the price target was raised and does not provide Eli Lilly's actual share price.
Risks and unknowns
The material does not provide JPMorgan's original research report, so its full content cannot be verified.
The specific basis for the price target increase was not stated.
Whether the rating was adjusted at the same time was not stated.
The original text only says “September 28”; the year was not specified.
Related Developments
Loading event timeline…
Related concepts
price target
This term is not in the glossary yet. Browse related concepts in the glossary.